Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 2/2017

01-05-2017 | Original Article

High dose of radioactive iodine per se has no effect on glucose metabolism in thyroidectomized rats

Authors: Roghaieh Samadi, Mahboubeh Ghanbari, Babak Shafiei, Sevda Gheibi, Fereidoun Azizi, Asghar Ghasemi

Published in: Endocrine | Issue 2/2017

Login to get access

Abstract

Purpose

Thyroid concentrates radioactive iodine by sodium-iodide symporter; this is used for treating hyperthyroidism and thyroid cancer. Pancreas expresses NIS and radioactive iodine uptake may damage pancreatic beta-cells and predispose patients to type 2 diabetes. The aim of this study was to determine whether radioactive iodine is associated with glucose metabolism in thyroidectomized rats.

Methods

Forty male Wistar rats were divided into four groups (n = 10/each); control, thyroidectomized, thyroidectomized-treated with 131-I (TX+I), and thyroidectomized-treated with 131-I and l-thyroxine (TX+I+T4). At the end of study, serum fasting glucose, insulin, thyroid-stimulating hormone, and free tetraiodothyronine were measured, intraperitoneal glucose tolerance test was performed, and homeostasis model assessment-insulin resistance was calculated. In in vitro experiments, glucose-stimulated insulin secretion from pancreatic islets and sodium-iodide symporter mRNA expression in thyroid and islets were determined.

Results

Compared to control group, free tetraiodothyronine was lower by 41 and 77% and thyroid-stimulating hormone was higher by 36 and 126% in thyroidectomized and TX+I groups, respectively. Compared to controls, rats in TX+I group had glucose intolerance as assessed using the area under curve of intraperitoneal glucose tolerance test (12,376 ± 542 vs. 20,769 ± 1070, P < 0.001) and l-thyroxine replacement therapy restored the value (14,286 ± 328.24) to near normal. Fasting insulin and homeostasis model assessment-insulin resistance were comparable in all groups, however fasting glucose was higher in TX+I group. In in vitro experiments, glucose-stimulated insulin secretion from islets did not differ between groups.

Conclusion

Radioactive iodine therapy per se had no effect on glucose metabolism, just intensified thyroid hormone deficiency and the alterations on glucose metabolism in thyroidectomized rats. l-thyroxine therapy restored the glucose intolerance observed in radioactive iodine-treated thyroidectomized rats.
Literature
1.
C.T. Sawin, D.V. Becker, Radioiodine and the treatment of hyperthyroidism: the early history. Thyroid 7, 163–176 (1997)CrossRef
2.
D.A. Pryma, S.J. Mandel, Radioiodine therapy for thyroid cancer in the era of risk stratification and alternative targeted therapies. J. Nucl. Med. 55, 1485–1491 (2014)CrossRef
3.
J.K. Fernandes, T.A. Day, M.S. Richardson, A.K. Sharma, Overview of the management of differentiated thyroid cancer. Curr. Treat. Options Oncol. 6, 47–57 (2005)CrossRef
4.
O. Dohan, A. De la Vieja, V. Paroder, C. Riedel, M. Artani, M. Reed et al., The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance. Endocr. Rev. 24, 48–77 (2003)CrossRef
5.
O. Levy, A. De la Vieja, N. Carrasco, The Na+/I− symporter (NIS): recent advances. J. Bioenerg. Biomembr 30, 195–206 (1998)CrossRef
6.
P.S. Sundaram, S. Padma, S. Sudha, K. Sasikala, Transient cytotoxicity of 131I beta radiation in hyperthyroid patients treated with radioactive iodine. Indian J. Med. Res. 133, 401–406 (2011)
7.
S.A. Rivkees, C. Dinauer. The use of 131 Iodine in the treatment of Graves’ disease in children. in Comprehensive Handbook of Iodine: Nutritional, Biochemical, Pathological and Therapeutic Aspects. ed. by V.R. Preedy, G.N. Burrow, R. Watson (Academic, Boston, MA, 2009), pp. 943–992
8.
R. Samadi, B. Shafiei, F. Azizi, A. Ghasemi, Radioactive iodine therapy and glucose tolerance. Cell J. 19, 184–193 (2017)PubMedPubMedCentral
9.
W. Grzesiuk, J. Nieminuszczy, M. Kruszewski, T. Iwanienko, M. Plazinska, M. Bogdanska et al., DNA damage and its repair in lymphocytes and thyroid nodule cells during radioiodine therapy in patients with hyperthyroidism. J. Mol. Endocrinol. 37, 527–532 (2006)CrossRef
10.
C. Spitzweg, W. Joba, K. Schriever, J.R. Goellner, J.C. Morris, A.E. Heufelder, Analysis of human sodium iodide symporter immunoreactivity in human exocrine glands. J. Clin. Endocrinol. Metab. 84, 4178–4184 (1999)PubMed
11.
L. Vayre, J.-C. Sabourin, B. Caillou, M. Ducreux, M. Schlumberger, J.-M. Bidart, Immunohistochemical analysis of Na+/I-symporter distribution in human extra-thyroidal tissues. Eur. J. Endocrinol. 141, 382–386 (1999)CrossRef
12.
C. Spitzweg, W. Joba, W. Eisenmenger, A.E. Heufelder, Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa. J. Clin. Endocrinol. Metab. 83, 1746–1751 (1998)CrossRef
13.
I.L. Wapnir, M. van de Rijn, K. Nowels, P.S. Amenta, K. Walton, K. Montgomery et al., Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections. J. Clin. Endocrinol. Metab. 88, 1880–1888 (2003)CrossRef
14.
T. Mitsuma, N. Rhue, Y. Hirooka, M. Kayama, Y. Yokoi, Y. Mori et al., Organ distribution of iodide transporter (symporter) in the rat: immunohistochemical study. Endocr. Regul. 31, 15–18 (1997)PubMed
15.
R.M. Dwyer, E.R. Bergert, M.K. O’Connor, S.J. Gendler, J.C. Morris, Adenovirus-mediated and targeted expression of the sodium-iodide symporter permits in vivo radioiodide imaging and therapy of pancreatic tumors. Hum. Gene Ther. 17, 661–668 (2006)CrossRef
16.
R. Solans, J.-A. Bosch, P. Galofre, F. Porta, J. Rosello, A. Selva-O Callagan et al., Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy. J. Nucl. Med. 42, 738–743 (2001)PubMed
17.
N. Eijun, K. Masafumi, Glucose tolerance evaluation in graves patients treated with methimazole and radioiodine. Int. J. Endocrinol. Metab 2011, 377–378 (2011)
18.
S.A. Durmaz, A. Carlioglu, E. Simsek, M. Demirci, H. Sevimli, Does radioactive iodine ablation treatment in patients with hyperthyroidism effect on glucose metabolism? Endocrine 35, 1025 (2014)
19.
J. Kiani, V. Yusefi, M. Tohidi, Y. Mehrabi, F. Azizi, Evaluation of glucose tolerance in methimazole and radioiodine treated Graves’ patients. Int. J. Endocrinol. Metab. 8, 132–137 (2010)
20.
B. Hallengren, A. Falorni, M. Landin-Olsson, A. Lernmark, K.I. Papadopoulos, G. Sundkvist, Islet cell and glutamic acid decarboxylase antibodies in hyperthyroid patients: at diagnosis and following treatment. J. Intern. Med. 239, 63–68 (1996)CrossRef
21.
R.J. Robbins, M.J. Schlumberger, The evolving role of 131I for the treatment of differentiated thyroid carcinoma. J. Nucl. Med. 46, 28S–37S (2005)PubMed
22.
D. Piciu. Nuclear Endocrinology. (Springer Science & Business Media, Heidelberg, (2012)CrossRef
23.
M. Luster, S.E. Clarke, M. Dietlein, M. Lassmann, P. Lind, W.J.G. Oyen et al., Guidelines for radioiodine therapy of differentiated thyroid cancer. Eur. J. Nucl. Med. Mol. Imaging 35, 1941–1959 (2008)CrossRef
24.
J.C. Francisco, R.C. Cunha, M.A. Cardoso, R.B. Simeoni, L.C. Guarita-Souza, The effects of total thyroidectomy on cardiac function in old rats using echocardiographic measures. J. Clin. Exp. Cardiol. 11, 2–5 (2013)
25.
L.A. Nolan, C.K. Thomas, A. Levy, Permissive effects of thyroid hormones on rat anterior pituitary mitotic activity. J. Endocrinol. 180, 35–43 (2004)CrossRef
26.
P.E. Lacy, M. Kostianovsky, Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16, 35–39 (1967)CrossRef
27.
N. Karbalaei, A. Ghasemi, F. Faraji, S. Zahediasl, Comparison of the effect of maternal hypothyroidism on carbohydrate metabolism in young and aged male offspring in rats. Scand. J. Clin. Lab. Invest. 73, 87–94 (2013)CrossRef
28.
M. Tohidi, A. Ghasemi, F. Hadaegh, A. Derakhshan, A. Chary, F. Azizi, Age- and sex-specific reference values for fasting serum insulin levels and insulin resistance/sensitivity indices in healthy Iranian adults: tehran lipid and glucose study. Clin. Biochem. 47, 432–438 (2014)CrossRef
29.
A. Godini, A. Ghasemi, N. Karbalaei, S. Zahediasl, The effect of thyroidectomy and propylthiouracil-induced hypothyroidism on insulin secretion in male rats. Horm. Metab. Res. 46, 710–716 (2014)CrossRef
30.
M.-L. Doong, J.W.-C. Wang, S.-C. Chung, J.-Y. Liu, C. Hwang, C.-Y. Hwang et al., Regulation of thyroid hormones in the secretion of insulin and gastric inhibitory polypeptide in male rats. Metabolism 46, 154–158 (1997)CrossRef
31.
H. Nagao, T. Imazu, H. Hayashi, K. Takahashi, K. Minato, Influence of thyroidectomy on thyroxine metabolism and turnover rate in rats. J. Endocrinol. 210, 117–123 (2011)CrossRef
32.
N. Katsilambros, R. Ziegler, H. Schatz, M. Hinz, V. Maier, E.F. Pfeiffer, Intravenous glucose tolerance and insulin secretion in the rat after thyroidectomy. Horm. Metab. Res. 4, 377–379 (1972)CrossRef
33.
S. Lenzen, H.G. Joost, A. Hasselblatt, Thyroid function and insulin secretion from the perfused pancreas in the rat. Endocrinology 99, 125–129 (1976)CrossRef
34.
W.J. Malaisse, F. Malaisse-Lagae, E.F. McCraw, Effects of thyroid function upon insulin secretion. Diabetes 16, 643–646 (1967)CrossRef
35.
M. Gierach, J. Gierach, R. Junik, Insulin resistance and thyroid disorders. Endokrynol. Pol. 65, 70–76 (2014)CrossRef
36.
A. Handisurya, G. Pacini, A. Tura, A. Gessl, A. Kautzky-Willer, Effects of T4 replacement therapy on glucose metabolism in subjects with subclinical (SH) and overt hypothyroidism (OH). Clin. Endocrinol. 69, 963–969 (2008)CrossRef
37.
A. Montes, F. Hervas, T. John, Effects of thyroidectomy and thyroxine on plasma growth hormone and insulin levels in rats. Hormones 8, 148–158 (1977)CrossRef
38.
N. Dariyerli, G. Andican, A.B. Catakoglu, H. Hatemi, G. Burcak, Hyperuricemia in hypothyroidism: is it associated with post-insulin infusion glycemic response? Tohoku J. Exp. Med. 199, 59–68 (2003)CrossRef
39.
M. Owecki, E. Nikisch, J. Sowinski, Hypothyroidism has no impact on insulin sensitivity assessed with HOMA-IR in totally thyroidectomized patients. Acta Clin. Belg. 61, 69–73 (2006)CrossRef
40.
A.M. Nada, Effect of treatment of overt hypothyroidism on insulin resistance. World J. Diabetes 4, 157–161 (2013)CrossRef
41.
G. Brenta, F.S. Celi, M. Pisarev, M. Schnitman, I. Sinay, P. Arias, Acute thyroid hormone withdrawal in athyreotic patients results in a state of insulin resistance. Thyroid 19, 665–669 (2009)CrossRef
42.
G. Dimitriadis, P. Mitrou, V. Lambadiari, E. Boutati, E. Maratou, D.B. Panagiotakos et al., Insulin action in adipose tissue and muscle in hypothyroidism. J. Clin. Endocrinol. Metab. 91, 4930–4937 (2006)CrossRef
43.
M.A. Pisarev, Interrelationships between the pancreas and the thyroid. Curr. Opin. Endocrinol. Diabetes Obes. 17, 437–439 (2010)CrossRef
44.
G. Dimitriadis, E. Maratou, M. Alevizaki, E. Boutati, K. Psara, C. Papasteriades et al., Thyroid hormone excess increases basal and insulin-stimulated recruitment of GLUT3 glucose transporters on cell surface. Horm. Metab. Res. 37, 15–20 (2005)CrossRef
45.
A.M. Cortizo, D.C.L. Gomez, J.J. Gagliardino, Effect of thyroid hormone levels upon pancreatic islet function. Acta Physiol. Pharmacol. Latinoam. 35, 181–191 (1985)PubMed
46.
G. Dimitriadis, B. Baker, H. Marsh, L. Mandarino, R. Rizza, R. Bergman et al., Effect of thyroid hormone excess on action, secretion, and metabolism of insulin in humans. Am. J. Physiol. 248, E593–E601 (1985)PubMed
47.
C.P. Reilly, R.G. Symons, M.L. Wellby, A rat model of the 131I-induced changes in thyroid function. J. Endocrinol. Invest. 9, 367–370 (1986)CrossRef
48.
V. Torlak, T. Zemunik, D. Modun, V. Capkun, V. Pesutic-Pisac, A. Markotic et al., 131I-induced changes in rat thyroid gland function. Braz. J. Med. Biol. Res. 40, 1087–1094 (2007)CrossRef
49.
N. Karbalaei, A. Ghasemi, M. Hedayati, A. Godini, S. Zahediasl, The possible mechanisms by which maternal hypothyroidism impairs insulin secretion in adult male offspring in rats. Exp. Physiol. 99, 701–714 (2014)CrossRef
50.
C. Alva-Sánchez, J. Pacheco-Rosado, T. Fregoso-Aguilar, I. Villanueva, The long-term regulation of food intake and body weight depends on the availability of thyroid hormones in the brain. Neuroendocrinol. Lett. 33, 703–708 (2012)PubMed
51.
V. Usenko, E. Lepekhin, V. Lyzogubov, I. Kornilovska, G. Ushakova, M. Witt, The influence of low doses 131 I-induced maternal hypothyroidism on the development of rat embryos. Exp. Toxicol. Pathol. 51, 223–227 (1999)CrossRef
52.
S. Wu, G. Tan, X. Dong, Z. Zhu, W. Li, Z. Lou et al., Metabolic profiling provides a system understanding of hypothyroidism in rats and its application. PLoS One. 8, e55599 (2013)CrossRef
53.
A. Herwig, G. Campbell, C.-D. Mayer, A. Boelen, R.A. Anderson, A.W. Ross et al., A thyroid hormone challenge in hypothyroid rats identifies T3 regulated genes in the hypothalamus and in models with altered energy balance and glucose homeostasis. Thyroid 24, 1575–1593 (2014)CrossRef
54.
M.A. Syed, M.P. Thompson, J. Pachucki, L.A. Burmeister, The effect of thyroid hormone on size of fat depots accounts for most of the changes in leptin mRNA and serum levels in the rat. Thyroid 9, 503–512 (1999)CrossRef
55.
A. Muniesa, M. Llobera, E. Herrera, Adipose tissue cellularity in hypo- and hyperthyroid rats. Horm. Res. Paediatr. 11, 254–261 (1979)CrossRef
56.
D. Salvatore, T.F. Davies, M. Schlumberger, I.D. Hay, P.R. Larsen. Thyroid physiology and diagnostic evaluation of patients with thyroid disorders. Williams Textbook of Endocrinology. ed. by S. Melmed, K.S. Polonsky, P.R. Larsen, H.M. Kronenberg (Elsevier Health Sciences, Philadelphia, PA, 2011) pp. 327–475CrossRef
57.
C. La Vecchia, M. Malvezzi, C. Bosetti, W. Garavello, P. Bertuccio, F. Levi et al., Thyroid cancer mortality and incidence: a global overview. Int. J. Cancer 136, 2187–2195 (2015)CrossRef
58.
S. Reichlin, J.B. Martin, R.L. Boshans, D.S. Schalch, J.G. Pierce, J. Bollinger, Measurement of TSH in plasma and pituitary of the rat by a radioimmunoassay utilizing bovine TSH: effect of thyroidectomy or thyroxine administration on plasma TSH levels. Endocrinology 87, 1022–1031 (1970)CrossRef
59.
J.W. Fisher, E.D. McLanahan. Computational model for iodide economy and the HPT axis in the adult rat. Quantitative Modeling in Toxicology. ed. by M.E.A. Kannan Krishnan (Wiley, Chichester, 2010) p. 262
60.
N. Tonooka, S. Kobayashi, Effect of propylthiouracil on nycthemeral and sex related variation of plasma TSH in rats. Endocrinol. Jpn 27, 27–32 (1980)CrossRef
Metadata
Title
High dose of radioactive iodine per se has no effect on glucose metabolism in thyroidectomized rats
Authors
Roghaieh Samadi
Mahboubeh Ghanbari
Babak Shafiei
Sevda Gheibi
Fereidoun Azizi
Asghar Ghasemi
Publication date
01-05-2017
Publisher
Springer US
Published in
Endocrine / Issue 2/2017
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-017-1274-9

Other articles of this Issue 2/2017

Endocrine 2/2017 Go to the issue

Original Article

Growth hormone and cortisol secretion in the elderly evaluated using the glucagon stimulation test

Original Article

The changing faces of corticotroph cell adenomas: the role of prohormone convertase 1/3

Review

Insights into the relationships between diabetes, prediabetes, and cancer

Original Article

In vitro effects of zinc, D-aspartic acid, and coenzyme-Q10 on sperm function

Original Article

Presence of headache and headache types in patients with tumors of the sellar region—can surgery solve the problem? Results of a prospective single center study

Research Letter

Risk of malignancy in 1502 solid thyroid nodules >1 cm using the new ultrasonographic classification of the American Thyroid Association

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits